These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 30590197)
1. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha. Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197 [TBL] [Abstract][Full Text] [Related]
2. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase. Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089 [TBL] [Abstract][Full Text] [Related]
3. Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways. Liu X; Lian J; Hu CH; Deng C Pharmacol Res; 2015 Oct; 100():36-46. PubMed ID: 26218603 [TBL] [Abstract][Full Text] [Related]
4. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. Luo L; Fang K; Dan X; Gu M Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686 [TBL] [Abstract][Full Text] [Related]
5. Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2. Zhao Y; Pan Y; Yang Y; Batey R; Wang J; Li Y J Transl Med; 2015 Jun; 13():174. PubMed ID: 26031670 [TBL] [Abstract][Full Text] [Related]
6. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375 [TBL] [Abstract][Full Text] [Related]
7. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation. Choi du G; Kim EK; Yang JW; Song JS; Kim YM Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190 [TBL] [Abstract][Full Text] [Related]
8. Longdan Xiegan Tang attenuates liver injury and hepatic insulin resistance by regulating the angiotensin-converting enzyme 2/Ang (1-7)/Mas axis-mediated anti-inflammatory pathway in rats. Wang C; Ren L; Chen S; Zheng H; Yang Y; Gu T; Li Y; Wang C J Ethnopharmacol; 2021 Jun; 274():114072. PubMed ID: 33781876 [TBL] [Abstract][Full Text] [Related]
10. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice. López-Oliva ME; Garcimartin A; Muñoz-Martínez E Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234 [TBL] [Abstract][Full Text] [Related]
11. The ancient Chinese formula Longdan Xiegan Tang improves antipsychotic-induced hyperprolactinemia by repairing the hypothalamic and pituitary TGF-β1 signaling in rats. Ren L; Liu W; Wang C; Yang Y; Huang X; Wang C; Li Y J Ethnopharmacol; 2020 May; 254():112572. PubMed ID: 31940455 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation. Li H; Ying H; Hu A; Hu Y; Li D Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350 [TBL] [Abstract][Full Text] [Related]
13. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [TBL] [Abstract][Full Text] [Related]
14. Effects of Mun J; Park J; Yoon HG; You Y; Choi KC; Lee YH; Kim K; Lee J; Kim OK; Jun W J Med Food; 2019 Dec; 22(12):1262-1270. PubMed ID: 31834842 [TBL] [Abstract][Full Text] [Related]
15. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice. Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945 [TBL] [Abstract][Full Text] [Related]
16. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399 [TBL] [Abstract][Full Text] [Related]